Mechelen, Belgium

Frank De Smet


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 271(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Patient Care: The Automated Insulin Monitoring System by Frank De Smet

Introduction

Frank De Smet, an inventive mind from Mechelen, Belgium, has made significant contributions to the field of medical technology. With a focus on enhancing patient care in intensive care units (ICUs), De Smet's work is both innovative and essential for improving the management of critically ill patients.

Latest Patents

De Smet holds one notable patent titled "Automatic Infusion System Based on an Adaptive Patient Model." This invention addresses the monitoring of blood glucose levels and the administration of insulin for strict normoglycemia maintenance in ICU patients. The system not only reduces the morbidity and mortality rates associated with intensive care but also highlights key factors that influence insulin dosage, including patient history, body mass index, and severity of illness.

Career Highlights

Working at K.U. Leuven Research & Development, Frank De Smet has honed his expertise in developing sophisticated healthcare solutions. His patent reflects a deep understanding of both medical needs and technological advancements, showcasing his ability to fuse these two fields for better patient outcomes.

Collaborations

De Smet collaborates with prominent colleagues like Greta Van Den Berghe and Daniel Berckmans, who also contribute to advancements in medical research and technology. These collaborations enrich his work and enhance the development of effective health monitoring systems.

Conclusion

Frank De Smet is a pioneering inventor whose contributions to automated insulin monitoring are vital for improving patient care in intensive settings. His patent not only demonstrates his innovative spirit but also offers a significant impact on the healthcare industry by optimizing insulin therapy for critically ill patients. Through his work and collaborations at K.U. Leuven Research & Development, De Smet is paving the way for future advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…